Willingness to Participate in HIV Vaccine Trials among Men Who Have Sex with Men in Chennai and Mumbai, India: A Social Ecological Approach
Open Access
- 4 December 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (12) , e51080
Abstract
Recruitment of low- and middle-income country volunteers from most-at-risk populations in HIV vaccine trials is essential to vaccine development. In India, men who have sex with men (MSM) are at disproportionately high risk for HIV infection and an important population for trial recruitment. Investigations of willingness to participate (WTP) in HIV vaccine trials have focused predominantly on individual-level determinants. We explored multi-level factors associated with WTP among MSM in India. We conducted 12 focus groups (n = 68) with low socioeconomic MSM in Chennai and Mumbai, and 14 key informant interviews with MSM community leaders and service providers. Focus groups/interviews were recorded, transcribed and translated into English. Two bilingual investigators conducted thematic analysis using line-by-line coding and a constant comparative method, with member-checking by community representatives. Factors associated with WTP were evidenced across the social ecology of MSM–social-structural: poverty, HIV-, sexual- and gender non-conformity stigma, institutionalized discrimination and government sponsorship of trials; community-level: endorsement by MSM community leaders and organizations, and fear of within-group discrimination; interpersonal: anticipated family discord, partner rejection, having financially-dependent family members and disclosure of same-sex sexuality; and individual-level: HIV vaccine trial knowledge and misconceptions, safety concerns, altruism and preventive misconception. Pervasive familial, community and social-structural factors characteristic of the Indian sociocultural context may complicate individual-focused approaches to WTP and thereby constrain the effectiveness of interventions to support recruitment and retention in HIV vaccine trials. Interventions to reduce stigma and discrimination against MSM and people living with HIV, capacity-building of MSM community organizations and transparent communications tailored to the knowledge and educational level of local communities may support meaningful engagement of MSM in HIV vaccine trials. Vigilance in providing fair but not excessive compensation and healthcare benefits and in mitigating preventive misconception are warranted to support ethical conduct of trials among MSM in India.Keywords
This publication has 29 references indexed in Scilit:
- “Once Bitten, Twice Shy”: Participant perspectives in the aftermath of an early HIV vaccine trial terminationVaccine, 2011
- Enhancing HIV Vaccine Trial Consent Preparedness among Street Drug UsersJournal of Empirical Research on Human Research Ethics, 2010
- Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South AfricaBMC Medical Ethics, 2010
- Bisexuality, Sexual Risk Taking, and HIV Prevalence Among Men Who Have Sex With Men Accessing Voluntary Counseling and Testing Services in Mumbai, IndiaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Community-Based Participatory Research From the Margin to the MainstreamCirculation, 2009
- Secondary HIV prevention amongKothi‐identified MSM in Chennai, IndiaCulture, Health & Sexuality, 2008
- Parents’ vaccination comprehension and decisionsVaccine, 2008
- Community heroes or “high-risk” pariahs? Reasons for declining to enroll in an HIV vaccine trialVaccine, 2008
- Ambiguities of ‘Culture’ and the Antiretroviral Rollout in South AfricaSocial Dynamics, 2005
- Lay perceptions of risk of HIV infection and the social construction of safer sex: Some experiences from KenyaAIDS Care, 1996